People: Adamas Pharmaceuticals Inc (ADMS.OQ)
30 Nov 2020
Mr. William W. Ericson serves as Independent Director of the Company. Mr. Ericson has been a Managing Director of Wildcat Venture Partners, a venture capital firm, since 2015. In addition, Mr. Ericson has been a General Partner at Mohr Davidow Ventures, or MDV, a venture capital firm, since 2000. Prior to joining MDV, Mr. Ericson founded and operated Venture Law Group LLP’s Seattle office from 1996 to 2000. Mr. Ericson currently serves as a member of the board of directors of Pacific Biosciences of California, Inc., a publicly traded gene sequencing company, Northwestern University School of Law, and a number of MDV’s privately held portfolio companies. Mr. Ericson previously served as a member of the board of directors of Rocket Fuel Inc., a publicly traded digital advertising company, from 2008 to 2017. Mr. Ericson holds a B.S.F.S. from the School of Foreign Service at Georgetown University and a J.D. from Northwestern University School of Law.
|Total Annual Compensation, USD||57,000|
|Restricted Stock Award, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||27,705|
|Fiscal Year Total, USD||84,705|